metformin
FDA Approved
Description
Metformin is a biguanide antidiabetic agent that improves insulin sensitivity and reduces hepatic glucose production. It is used off-label for severe insulin resistance syndromes including acanthosis nigricans-insulin resistance syndromes. The drug has a well-established safety profile with decades of clinical use.
Indications & Therapeutic Use
type 2 diabetes mellitus, insulin resistance syndromes, polycystic ovary syndrome
Linked Diseases:
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
metformin
| Generic Name | metformin |
| Brands | 1 brand available |
| Active Ingredient | metformin hydrochloride |
| Drug Class | type 2 diabetes mellitus |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | oral tablets 500mg/850mg/1000mg, extended-release tablets 500mg/750mg |
| Medical Code | A10BA02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes